African Impact Initiative
Overview
African Impact Initiative is a non-profit organization and investment firm that supports early-stage African entrepreneurs through its venture investment arm, the African Impact Fund, and its accelerator program, the African Impact Challenge.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SnooCODE | - | Accelerator | Co-investor |
| Telemedan | - | Accelerator | Co-investor |
| Remedius Mobile Health | Jun 2024 | Accelerator | Co-investor |
| Streamline Health Tech Ltd | - | Grant | Co-investor |
| Pana+Care | Dec 2025 | SAFE | Lead |
For institutional investors. Book with your work email.
Key People
Efosa KC Obano
Founder
Maryam Ebrahim
Digital Health Founder AIC 2026
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is African Impact Initiative based?
African Impact Initiative is headquartered in Toronto, Ontario, Canada.
When was African Impact Initiative founded?
African Impact Initiative was founded in 2016.
How many portfolio companies does African Impact Initiative have?
African Impact Initiative has 6 portfolio companies in Caplight's dataset.
What are some companies in African Impact Initiative's portfolio?
Portfolio companies visible on Caplight include SnooCODE, Telemedan, Remedius Mobile Health, Streamline Health Tech Ltd, Pana+Care.
What was African Impact Initiative's most recent investment shown here?
African Impact Initiative's most recent investment in this portfolio sample was in Pana+Care in 2025.
What sectors does African Impact Initiative focus on?
African Impact Initiative focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Mobility, Transportation & Logistics, Enterprise Software, Healthcare & Life Sciences, Consumer & Commerce, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does African Impact Initiative focus on?
African Impact Initiative typically invests at the Early stage.